Sato, Toshihiro, et al. “Role of OATP4C1 in Renal Handling of Remdesivir and Its Nucleoside Analog GS-441524: The First Approved Drug for Patients With COVID-19”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 24, May 2021, pp. 227-36, doi:10.18433/jpps31813.